121 related articles for article (PubMed ID: 38196304)
1. ALCAM is a biomarker of tumor aggressiveness and worse prognosis in glottic laryngeal squamous cell carcinoma.
Nicolau-Neto P; Peryassú BC; de Carvalho FN; Souza-Santos PT; Valverde P; Nascimento CM; Costa I; Dias FL; Pinto LFR
Head Neck; 2024 Apr; 46(4):785-796. PubMed ID: 38196304
[TBL] [Abstract][Full Text] [Related]
2. Transcriptome Analysis Identifies ALCAM Overexpression as a Prognosis Biomarker in Laryngeal Squamous Cell Carcinoma.
Nicolau-Neto P; de Souza-Santos PT; Severo Ramundo M; Valverde P; Martins I; Santos IC; Dias F; de Almeida Simão T; Ribeiro Pinto LF
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32085563
[TBL] [Abstract][Full Text] [Related]
3. Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas.
Wachters JE; Kop E; Slagter-Menkema L; Mastik M; van der Wal JE; van der Vegt B; de Bock GH; van der Laan BFAM; Schuuring E
Laryngoscope; 2020 Dec; 130(12):2825-2832. PubMed ID: 32065407
[TBL] [Abstract][Full Text] [Related]
4. The role of protein p16(INK4a) in glottic laryngeal squamous cell carcinoma.
Kalfert D; Celakovsky P; Laco J; Ludvikova M
Pathol Oncol Res; 2014 Oct; 20(4):909-15. PubMed ID: 24760498
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated FADD is not prognostic for local control in T1-T2 supraglottic laryngeal carcinoma treated with radiotherapy.
Wachters JE; Schrijvers ML; Slagter-Menkema L; Mastik M; Langendijk JA; de Bock GH; Roodenburg JL; van der Laan BFAM; van der Wal JE; Schuuring E
Laryngoscope; 2017 Sep; 127(9):E301-E307. PubMed ID: 28304089
[TBL] [Abstract][Full Text] [Related]
6. [Correlation of Rab coupling protein expression with clinicopathological characteristics and prognosis in laryngeal squamous cell carcinoma].
Dai Y; Liu Y; Tian X; Zhang X
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):101-6. PubMed ID: 25975685
[TBL] [Abstract][Full Text] [Related]
7. High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.
Giotakis AI; Kontos CK; Manolopoulos LD; Sismanis A; Konstadoulakis MM; Scorilas A
Clin Biochem; 2016 Aug; 49(12):890-6. PubMed ID: 27129795
[TBL] [Abstract][Full Text] [Related]
8. Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.
Li L; Wang J; Gao L; Gong L
Int J Clin Exp Pathol; 2015; 8(8):9232-9. PubMed ID: 26464671
[TBL] [Abstract][Full Text] [Related]
9. Impact of stage, management and recurrence on survival rates in laryngeal cancer.
Brandstorp-Boesen J; Sørum Falk R; Boysen M; Brøndbo K
PLoS One; 2017; 12(7):e0179371. PubMed ID: 28708883
[TBL] [Abstract][Full Text] [Related]
10. [The expression and clinical significance of Bax and PHF20 in laryngeal squamous cell carcinoma].
Zhang C; Gao W; Dong S; Chen G; Han R; Wen S; Wang B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Oct; 29(19):1701-5. PubMed ID: 26999840
[TBL] [Abstract][Full Text] [Related]
11. pT3 N0 Laryngeal Squamous Cell Carcinoma: Oncologic Outcomes and Prognostic Factors of Surgically Treated Patients.
Mattioli F; Fermi M; Molinari G; Capriotti V; Melegari G; Bertolini F; D'Angelo E; Tirelli G; Presutti L
Laryngoscope; 2021 Oct; 131(10):2262-2268. PubMed ID: 33755212
[TBL] [Abstract][Full Text] [Related]
12. Cyr61/CCN1 overexpression induces epithelial-mesenchymal transition leading to laryngeal tumor invasion and metastasis and poor prognosis.
Liu Y; Zhou YD; Xiao YL; Li MH; Wang Y; Kan X; Li QY; Lu JG; Jin DJ
Asian Pac J Cancer Prev; 2015; 16(7):2659-64. PubMed ID: 25854342
[TBL] [Abstract][Full Text] [Related]
13. Correlation between expression of Lin28B and C-myc in patients with laryngeal squamous cell carcinoma and clinicopathological features and prognosis.
Liao F; Cao Y; Huang M; Chu L; Wang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Feb; 48(2):165-171. PubMed ID: 36999462
[TBL] [Abstract][Full Text] [Related]
14. Expression of vimentin (VIM) and metastasis-associated 1 (MTA1) protein in laryngeal squamous cell carcinoma are associated with prognostic outcome of patients.
Karamagkiolas S; Giotakis I; Kyrodimos E; Giotakis EI; Kataki A; Karagianni F; Lazaris AM
Am J Otolaryngol; 2019; 40(4):487-493. PubMed ID: 30979652
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of pathological carcinoma size in patients with T2 glottic laryngeal squamous cell carcinoma.
Zhou J; Zhu X; Yang Y; Zhou L; Gong H; Xu C; Tao L
Acta Otolaryngol; 2023 Apr; 143(4):317-321. PubMed ID: 36994848
[TBL] [Abstract][Full Text] [Related]
16. Dickkopf-1 is a novel prognostic biomarker for laryngeal squamous cell carcinoma.
Shi Y; Gong HL; Zhou L; Tian J; Wang Y
Acta Otolaryngol; 2014 Jul; 134(7):753-9. PubMed ID: 24834937
[TBL] [Abstract][Full Text] [Related]
17. [Expression of long non-coding RNA LINC00460 in laryngeal squamous cell carcinoma tissue and its clinical significance].
Ge SS; Wu YY; Gao W; Zhang CM; Hou J; Wen SX; Wang BQ
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Jan; 32(1):18-22. PubMed ID: 29798204
[No Abstract] [Full Text] [Related]
18. LAMP1 expression is associated with malignant behaviours and predicts unfavourable prognosis in laryngeal squamous cell carcinoma.
Lu M; Zhu H; Wang X; Zhang D; Xiong L; Zhu J; Mao Y; Qiang J
Pathology; 2016 Dec; 48(7):684-690. PubMed ID: 27788920
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.
Fang R; Huang Y; Xie J; Zhang J; Ji X
Diagn Pathol; 2019 Oct; 14(1):109. PubMed ID: 31615536
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma.
Ahmed RA; Shawky Ael-A; Hamed RH
Pathol Oncol Res; 2014 Jul; 20(3):625-33. PubMed ID: 24470282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
